UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007900
Receipt number R000009155
Scientific Title Effect of Sitagliptin on Plaques and Cardiac Function following ACS
Date of disclosure of the study information 2012/05/07
Last modified on 2013/11/07 14:57:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Sitagliptin on Plaques and Cardiac Function following ACS

Acronym

ESPECIAL-ACS

Scientific Title

Effect of Sitagliptin on Plaques and Cardiac Function following ACS

Scientific Title:Acronym

ESPECIAL-ACS

Region

Japan


Condition

Condition

Acute Coronary Syndrome end Type 2 Diabetes Mellitus

Classification by specialty

Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

ESPECIAL trial will evaluate the effects of DPP4 inhibitor(Sitagliptin) on
coronary plaque regression in patients with acute coronary syndrome.
The study will also assess whether the efficacy of DPP4 inhibitor also
achieve plaque stabilization and improve left ventricular function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

percent change in coronary plaque volume

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Diet+ Exercise therapy and Sitagliptin 50-100mg/day

Interventions/Control_2

Diet+ Exercise therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients with Acute coronary syndrome
2)Patients with coronary plaques (&#8805;500micro m in thickness or 20% or more in % plaque) at &#8805;5mm from the previously treated area in the same branch of coronary artery.
3)Patients undergoing successful percutaneous coronary intervention (PCI) under IB-IVUS guidance to culprit lesion
4)Patients eating oral diet and drug within 72 hours
5)Patients with diabetes as defined by any of the following criteria: (1) NGSP HbA1c between 6.5% and 7.4% without diabetic drug; (2) NGSP HbA1c less than 7.4% using diabetic drug
6)Patients between 20 years and 80 years old at the time of their consent.
7)Patients giving written consent by their own volition after being provided sufficient explanation for participation in this clinical trial.

Key exclusion criteria

1)diseased bypass graft
2)Patients who have plaque in a non-culprit site on the PCI vessel and might undergo PCI during the treatment period.
3)Patients receiving DPP4 inhibitor drugs and GLP-1 and high dose SU drugs at admission
4)Patients receiving more than 3 anti-diabetic drugs
5)Patients with acute congestive heart failure
6)Patients with ketoacidosis and diabetic coma within 6 months
7)Severe infection, Pre-operative and post-operative state, and severe trauma
8)Pregnant women, women suspected of being pregnant, or lactating women
9)Patients with severe renal disorders or undergoing dialysis
10)Patients with active malignant tumor
11)Patients with any allergy to DPP4 inhibitor
12)Patients who are ineligible in the opinion of the investigator.

Target sample size

46


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Daida

Organization

Juntendo University

Division name

Cardiovascular Medicine

Zip code


Address

2-1-1 Hongo Bunkyo-ku Tokyo

TEL

03-3813-3111

Email

ktmmy@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Katsumi Miyauchi

Organization

Juntendo University

Division name

Cardiovascular Medicine

Zip code


Address

2-1-1 Bunkyo-ku Hongo,Tokyo

TEL

03-3813-3111

Homepage URL


Email

ktmmy@juntendo.ac.jp


Sponsor or person

Institute

ESPECIAL-ACS office

Institute

Department

Personal name



Funding Source

Organization

The Kidney Foundation, Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 03 Month 09 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2013 Year 12 Month 01 Day

Date of closure to data entry

2014 Year 03 Month 01 Day

Date trial data considered complete

2014 Year 03 Month 01 Day

Date analysis concluded

2014 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 05 Month 07 Day

Last modified on

2013 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009155


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name